Extramammary Paget disease is characterized by the consistent lack of estrogen and progesterone receptors but frequently expresses androgen receptor.

Extramammary Paget disease (EPD) is an uncommon cutaneous malignant neoplasm that arises in areas rich in apocrine glands (perineum, vulva, and axilla). Apocrine gland origin or apocrine differentiation of cells of EPD has been suggested. Estrongen, progesterone, and androgen hormone receptors have been reported to exhibit a characteristic pattern of expression in mammary apocrine type carcinomas; however, their expression in EPD has not been elucidated fully. By using immunohistochemical methods, we studied the expression of steroid receptors in EPD on formalin-fixed paraffin-embedded tissue samples from 28 patients with EPD without associated visceral malignant neoplasms or adnexal carcinoma. Androgen receptor (AR) was identified in 15 of 28 cases. The proportion of AR-positive cells varied from 1% to more than 75%; 8 cases expressed AR in more than 10% of cells. Strong AR expression also was seen in the invasive carcinoma arising from 1 case of EPD. All cases lacked immunohistochemically detectable estrogen and progesterone receptors. The immunophenotype characteristic of apocrine carcinomas (AR-positive, estrogen receptor-negative, progesterone receptor-negative) was seen in a substantial proportion of EPD cases. Results suggest that AR expression is a factor in pathogenesis of EPD. This may be important for the therapy of recurrent or invasive disease.

[1]  C. Schuerch,et al.  Paget's disease of the vulva: prevalence of associated vulvar adenocarcinoma, invasive Paget's disease, and recurrence after surgical excision. , 1999, American journal of obstetrics and gynecology.

[2]  B. Smoller,et al.  The differential diagnosis of pagetoid cells in the epidermis. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[3]  L. Burgart,et al.  Paget's disease of the perianal region—An aggressive disease? , 1997, Diseases of the colon and rectum.

[4]  D. Page,et al.  Cytokeratins, CEA, and mucin histochemistry in the diagnosis and characterization of extramammary Paget's disease. , 1997, American journal of clinical pathology.

[5]  P. Disaia,et al.  Extramammary Paget's disease of the vulva: metastases to the bone marrow in the absence of an underlying adenocarcinoma--case report and literature review. , 1997, Gynecologic oncology.

[6]  Z. Gatalica,et al.  Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ. , 1997, Pathology, research and practice.

[7]  L. Requena,et al.  Epidermotropically metastatic breast carcinomas. Rare histopathologic variants mimicking melanoma and Paget's disease. , 1996, The American Journal of dermatopathology.

[8]  J. Feldman,et al.  Estrogen receptor immunocytochemistry in paraffin embedded tissues with ER1D5 predicts breast cancer endocrine response more accurately than H222Spγ in frozen sections or cytosol‐based ligand‐binding assays , 1996, Cancer.

[9]  R. Kürzl Paget's disease. , 1996, Seminars in dermatology.

[10]  D. Horsfall,et al.  Medroxyprogesterone acetate therapy in advanced breast cancer: the predictive value of androgen receptor expression. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  R. Pye,et al.  Treatment of extramammary Paget's disease by radiotherapy , 1995, The British journal of dermatology.

[12]  D. Horsfall,et al.  Androgens induce divergent proliferative responses in human breast cancer cell lines , 1995, The Journal of Steroid Biochemistry and Molecular Biology.

[13]  N. Shikata,et al.  Expression of androgen receptors in skin appendage tumors: An immunohistochemical study , 1995, Journal of cutaneous pathology.

[14]  N. Shikata,et al.  Immunohistochemical study of mammary and extramammary Paget's disease. , 1995, Anticancer research.

[15]  P. di Sant'Agnese,et al.  Androgen receptor immunostaining and its tissue distribution in formalin-fixed, paraffin-embedded sections after microwave treatment. , 1994, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[16]  R. Sutherland,et al.  MDA-MB-453, an androgen-responsive human breast carcinoma cell line with high level androgen receptor expression. , 1994, European journal of cancer.

[17]  D. Cotton Melanocytic Tumors of the Skin. Atlas of Tumor Pathology , 1992 .

[18]  T. H. van der Kwast,et al.  Localization of androgen receptors in human skin by immunohistochemistry: implications for the hormonal regulation of hair growth, sebaceous glands and sweat glands. , 1992, The Journal of endocrinology.

[19]  H. Yoshida,et al.  Stimulation of growth by both androgen and estrogen of the EMP-K1 transplantable tumor with androgen and estrogen receptors from human extramammary Paget's disease in nude mice. , 1992, Journal of the National Cancer Institute.

[20]  S. Mills,et al.  Immunoreactivity for Estrogen Receptor Protein in Sweat Gland Tumors , 1991, The American journal of surgical pathology.

[21]  B. Lloveras,et al.  Estrogen receptors in skin appendage tumors and extramammary Paget's disease. , 1991, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[22]  D. Elder,et al.  Non-melanocytic tumors of the skin , 1991 .

[23]  W. R. Hart,et al.  Progression of intraepithelial Paget's disease of the vulva to invasive carcinoma , 1977 .

[24]  M. Piver,et al.  Paget's Disease of the Vulva A Clinicopathologic Study of Eight Cases , 1975, Obstetrics and gynecology.

[25]  Harlan I. Firminger,et al.  Atlas of tumor pathology , 1954 .